Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3Antagonists

Abstract

The α V β 3 integrin is implicated in human tumor metastasis and in angiogenesis. The design of low-molecular-mass α V β 3 antagonists by “spatial screening” led to the highly active peptides c(RGD F V) and c(RGDF V ). Here the influence of the amino acids in positions 4 and 5 flanking the RGD-sequence on the inhibition of vitronectin and fibrinogen binding to the isolated α V β 3 and α IIb β 3 receptors was investigated. The influence of the side chain and the backbone conformation on activity and selectivity was studied. The compounds were divided into conformational classes. For each class at least one representative peptide was subjected to detailed structure determination in solution. The peptides of classes 1, 2, and 3 show a βII‘/γ-turn arrangement with the d -amino acid in the i + 1 position of the βII‘-turn. By contrast, the peptides of class 4 reveal a modified βII‘/γ-turn pattern with glycine in the i + 1 position of the βII‘-turn and the d -amino acid in the i + 1 position of the γ-turn. Class 1 is divided into two subclasses: besides the βII‘/γ-turn arrangement a γ/γ-turn motif is found for two members of this class. Structure−activity relationship (SAR) investigations show that the amino acid in position 4 and the proton of the amide bond between residues 3 and 4 are essential for high biological activities toward α V β 3 . By contrast, the amino acid in position 5 has no influence on the activity. A bent conformation of the RGD-sequence, as observed for the peptides of classes 1 and 2, fits the α V β 3 better than the α IIb β 3 receptor and so increases the selectivity of these peptides.